ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a … | News
Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of…
Browsing Tag